[11][12] Eckert began her career with Merck, before moving on to work with smaller, specialty pharmaceutical companies Dura and Elan.

Slate was focused on men's sexual health with an FDA approved long acting testosterone product, Testopel.

[18][19] To date, The Pink Ceiling has invested in eleven start-ups, with public announcements on their involvement with Undercover Colors (a company that is developing wearable nail tech to detect the presence of a date rape drug in drinks),[15] Lia Diagnostics (which produces a flushable pregnancy test),[20] Intuitap (which has a medical device aimed to streamline the spinal tap procedure),[4] and Pursuit (which is developing a patented technology to improve four different aspects of sleep)[21] The Pink Ceiling's affiliated incubator, called the “Pinkubator” because of its female focus, is located in Raleigh, North Carolina.

The “Pinkubator” was established to provide female-focused entrepreneurs with direct access to mentors, investment opportunities, and business development guidance.

[11] Eckert's drug Addyi has faced rampant criticism from scientists and physicians due to lack of efficacy and a PR campaign waged by her company Sprout Pharmaceuticals against the FDA.